DOCSLIB.ORG
  • Sign Up
  • Log In
  • Upload
  • Sign Up
  • Log In
  • Upload
  • Home
  • »  Tags
  • »  Abecarnil

Abecarnil

  • Guaiana, G., Barbui, C., Caldwell, DM, Davies, SJC, Furukawa, TA

    Guaiana, G., Barbui, C., Caldwell, DM, Davies, SJC, Furukawa, TA

  • GABA Receptors

    GABA Receptors

  • Neurobiological and Neurobehavioral Mechanisms of Chronic Alcohol Drinking

    Neurobiological and Neurobehavioral Mechanisms of Chronic Alcohol Drinking

  • Alprazolam Dependence Prevented by Substituting with the ß-Carboline

    Alprazolam Dependence Prevented by Substituting with the ß-Carboline

  • Abecarnil/Allobarbital 959 Pharmacopoeias

    Abecarnil/Allobarbital 959 Pharmacopoeias

  • WO 2015/072852 Al 21 May 2015 (21.05.2015) P O P C T

    WO 2015/072852 Al 21 May 2015 (21.05.2015) P O P C T

  • CNS Drug Reviews Vol

    CNS Drug Reviews Vol

  • Molecular Mechanisms of Antiseizure Drug Activity at GABAA Receptors

    Molecular Mechanisms of Antiseizure Drug Activity at GABAA Receptors

  • The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances

    The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances

  • Pharmaceutical Composition and Dosage Forms for Administration of Hydrophobic Drugs

    Pharmaceutical Composition and Dosage Forms for Administration of Hydrophobic Drugs

  • Stembook 2018.Pdf

    Stembook 2018.Pdf

  • Abecarnil for the Treatment of Generalized Anxiety Disorder: a Placebo-Controlled Comparison of Two Dosage Ranges of Abecarnil and Buspirone

    Abecarnil for the Treatment of Generalized Anxiety Disorder: a Placebo-Controlled Comparison of Two Dosage Ranges of Abecarnil and Buspirone

  • (12) Patent Application Publication (10) Pub. No.: US 2010/0184806 A1 Barlow Et Al

    (12) Patent Application Publication (10) Pub. No.: US 2010/0184806 A1 Barlow Et Al

  • (2) Patent Application Publication (10) Pub. No.: US 2016/0015649 A1 Chen Et Al

    (2) Patent Application Publication (10) Pub. No.: US 2016/0015649 A1 Chen Et Al

  • GABAA Receptor Subtype- and Function-Selective Ligands: Key Issues in Translation to Humans

    GABAA Receptor Subtype- and Function-Selective Ligands: Key Issues in Translation to Humans

  • Ramelteon a Novel Hypnotic Lacking Abuse Liability and Sedative Adverse Effects

    Ramelteon a Novel Hypnotic Lacking Abuse Liability and Sedative Adverse Effects

  • Neuroscience of Psychoactive Substance Use and Dependence

    Neuroscience of Psychoactive Substance Use and Dependence

  • Detoxification and Substance Abuse Treatment

    Detoxification and Substance Abuse Treatment

Top View
  • Chemical Structure-Related Drug-Like Criteria of Global Approved Drugs
  • )&F1y3x PHARMACEUTICAL APPENDIX to THE
  • Aminobutyric Acid. What Can We Learn from Hydra Polyps?
  • The Gabaergic System: an Overview of Physiology, Physiopathology And
  • Drug-Resin Complexes Stabilized by Chelating Agents
  • Customs Tariff - Schedule Xxi - 1
  • Canadian Clinical Practice Guidelines for the Management of Anxiety
  • Wo 2007/044693 A2
  • Anxiety Disorders in Late Life
  • Partial Generalization in Drug Discrimination: Considerations for Interpretation
  • Stress and Drug Abuse-Related Disorders the Promising
  • Harmonized Tariff Schedule of the United States (2006) Annotated for Statistical Reporting Purposes
  • Acute Control of Repetitive Seizures and Status Epilepticus Using Alternative Routes of Administration of Benzodiazepines
  • Harmonized Tariff Schedule of the United States (2006) (Rev
  • Customs Tariff - Schedule Xxi - 1
  • Appendix E-3: Complete Search Strategy
  • Gabaergic Dysfunction in Mood Disorders
  • Søgeprotokol for NKR Angst Hos Voksne


© 2024 Docslib.org    Feedback